The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

People with Type 1 or Type 2 diabetes make up over a quarter of those waiting for an organ transplant in Wisconsin. People ...

With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...

Adults with diabetes, heart disease, heart failure, hypertension, or kidney failure may ignore dietary restrictions due to exposure to foods advertised during sporting events.

According to the National Kidney Foundation, 123,000 Americans are on that waitlist. More than a 100,000 of those waiting ...

Advice to eat less salt (sodium chloride) is not new. It has been part of international and Australian guidelines for decades ...

The WHO released a set of guidelines on Sunday recommending the use of lower-sodium salt substitutes, essentially including ...

Chronic kidney disease (CKD) is a growing global health concern, significantly contributing to morbidity and mortality rates worldwide. Characterized by a ...

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech ...